Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2020
Hetero launches Favivir 800/200 pack
Hetero said it launched Favivir 800/200, a pack of its generic oral antiviral favipiravir drug for mild-to-moderate symptomatic COVID-19 patients in India. The pack contains 16 tablets of 800 mg and two tablets of 200 mg and is priced at Rs 2,640.
2020
Hetero launches Favivir generic Favipiravir in India
Hetero launched Favivir, its generic Favipiravir, in India after receiving manufacturing and marketing approval from the Drug Controller General of India. The drug is prescription-only and priced at ₹59 per tablet.
2020
Hetero launches Favivir in India
Hetero said it launched Favivir, a generic oral antiviral drug for patients with mild to moderate COVID-19, in India at Rs 59 per tablet. The product was available from July 29, 2020, by prescription.
2020
Hetero receives approval for generic remdesivir
India’s Drug Controller-General approved Hetero to manufacture and sell its generic version of Gilead’s remdesivir for treating COVID-19 patients in India.
2019
Hetero launches Taffic in India
Hetero launched Taffic, a three-in-one antiretroviral combination drug used to treat HIV-1, in India. Hetero Healthcare will market and distribute the product in the country.